Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherosclerotic Cardiovascular Event”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Not applicableActive Not RecruitingNCT06855394
What this trial is testing

Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events

Who this might be right for
Atherosclerotic Vascular DiseaseCoronary Arterial Disease (CAD)Atherosclerosis of Coronary Artery+4 more
University of Florida 13,000
Post-approval studies (Phase 4)Looking for participantsNCT06501443
What this trial is testing

LATAM LOWERS LDL-C

Who this might be right for
Hypercholesterolaemia
Novartis Pharmaceuticals 520
Post-approval studies (Phase 4)Looking for participantsNCT06676280
What this trial is testing

ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography

Who this might be right for
Cardiovascular Diseases
Jung-min Ahn 5,000
Large-scale testing (Phase 3)Study completedNCT01663402
What this trial is testing

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

Who this might be right for
Atherosclerotic Cardiovascular Disease
Sanofi 18,924
Testing effectiveness (Phase 2)Study completedNCT05563246
What this trial is testing

LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Who this might be right for
Lipoprotein Disorder
Eli Lilly and Company 233
Not applicableUnknownNCT03897478
What this trial is testing

Biomarkers of Acute Stroke in Clinic

Who this might be right for
Ischemic StrokeIschemiaAtrial Fibrillation+14 more
Ischemia Care LLC 500
Not applicableStudy completedNCT03606330
What this trial is testing

Systemic, Pancoronary and Local Coronary Vulnerability

Who this might be right for
Coronary StenosisAcute Coronary SyndromeAcute Myocardial Infarction+3 more
Cardio Med Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT05537571
What this trial is testing

Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events

Who this might be right for
Cardiovascular DiseasesAtherosclerosisLipoprotein(a)
Silence Therapeutics plc 180
Not applicableStudy completedNCT04271280
What this trial is testing

Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events

Who this might be right for
DyslipidemiaCardiovascular DiseasesHypercholesterolemia+1 more
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 9,559
Large-scale testing (Phase 3)Active Not RecruitingNCT05360446
What this trial is testing

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

Who this might be right for
Coronary Artery Disease
Novartis Pharmaceuticals 609
Not applicableStudy completedNCT03499496
What this trial is testing

Screening for Atherotic Plaques by Ultrasound for Assessing Cardiovascular Risk

Who this might be right for
Atherosclerosis of Artery
Cabinet de Medecine Interne Générale Demetrio Pitarch 22
Not applicableLooking for participantsNCT06336174
What this trial is testing

Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study

Who this might be right for
Intracranial AtherosclerosisCognitive ImpairmentCerebrovascular Event
Anhui Medical University 100
Large-scale testing (Phase 3)Study completedNCT00799903
What this trial is testing

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Who this might be right for
Atherosclerosis
GlaxoSmithKline 15,828
Large-scale testing (Phase 3)Active Not RecruitingNCT05581303
What this trial is testing

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

Who this might be right for
Atherosclerotic Cardiovascular Disease
Amgen 7,297
Not applicableUnknownNCT03976804
What this trial is testing

Epidemiological Study to Assess the Prevalence of Lung Cancer

Who this might be right for
Lung CancerTobaccoAtherosclerotic Cardiovascular Event
Centre Chirurgical Marie Lannelongue 500
Not applicableStudy completedNCT00180466
What this trial is testing

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Who this might be right for
Coronary DiseaseCoronary Artery DiseaseCoronary Restenosis
Abbott Medical Devices 697
Large-scale testing (Phase 3)Looking for participantsNCT07000357
What this trial is testing

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 15,100
Not applicableStudy completedNCT00180492
What this trial is testing

Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE

Who this might be right for
Atherosclerotic Disease, Carotid
Abbott Medical Devices 1,500
Large-scale testing (Phase 3)Not Yet RecruitingNCT07572747
What this trial is testing

Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countries

Who this might be right for
Chronic Coronary Syndrome
Khalid F Alhabib 6,740
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07729475
What this trial is testing

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of Cardiovascular Events

Who this might be right for
Elevated Lipoprotein(a)
Shenzhen Salubris Pharmaceuticals Co., Ltd. 120
Next Page